These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27741251)

  • 1. High-Resolution 4C Reveals Rapid p53-Dependent Chromatin Reorganization of the CDKN1A Locus in Response to Stress.
    Millau JF; Wijchers P; Gaudreau L
    PLoS One; 2016; 11(10):e0163885. PubMed ID: 27741251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
    Fischer M; Quaas M; Nickel A; Engeland K
    Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
    Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
    Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcription factor p53: not a repressor, solely an activator.
    Fischer M; Steiner L; Engeland K
    Cell Cycle; 2014; 13(19):3037-58. PubMed ID: 25486564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition.
    Albert TK; Antrecht C; Kremmer E; Meisterernst M
    PLoS One; 2016; 11(1):e0146648. PubMed ID: 26745862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes.
    Gomes NP; Espinosa JM
    Cell Cycle; 2010 Sep; 9(17):3428-37. PubMed ID: 20818159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative Regulation of p21Waf1/Cip1 by Human INO80 Chromatin Remodeling Complex Is Implicated in Cell Cycle Phase G2/M Arrest and Abnormal Chromosome Stability.
    Cao L; Ding J; Dong L; Zhao J; Su J; Wang L; Sui Y; Zhao T; Wang F; Jin J; Cai Y
    PLoS One; 2015; 10(9):e0137411. PubMed ID: 26340092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 Pre- and post-binding event theories revisited: stresses reveal specific and dynamic p53-binding patterns on the p21 gene promoter.
    Millau JF; Bastien N; Bouchard EF; Drouin R
    Cancer Res; 2009 Nov; 69(21):8463-71. PubMed ID: 19843844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding.
    Gomes NP; Espinosa JM
    Genes Dev; 2010 May; 24(10):1022-34. PubMed ID: 20478995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAF53 interacts with p53 and functions in p53-mediated p21-gene transcription.
    Wang M; Gu C; Qi T; Tang W; Wang L; Wang S; Zeng X
    J Biochem; 2007 Nov; 142(5):613-20. PubMed ID: 17878219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced G1 cell-cycle arrest controls replication-dependent histone mRNA 3' end processing through p21, NPAT and CDK9.
    Pirngruber J; Johnsen SA
    Oncogene; 2010 May; 29(19):2853-63. PubMed ID: 20190802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner.
    Kramer HB; Lai CF; Patel H; Periyasamy M; Lin ML; Feller SM; Fuller-Pace FV; Meek DW; Ali S; Buluwela L
    Nucleic Acids Res; 2016 Jan; 44(2):582-94. PubMed ID: 26400164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
    Lin YC; Sun SH; Wang FF
    Cell Signal; 2011 Nov; 23(11):1816-23. PubMed ID: 21726628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK8 is a stimulus-specific positive coregulator of p53 target genes.
    Donner AJ; Szostek S; Hoover JM; Espinosa JM
    Mol Cell; 2007 Jul; 27(1):121-33. PubMed ID: 17612495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AP2alpha alters the transcriptional activity and stability of p53.
    Stabach PR; Thiyagarajan MM; Woodfield GW; Weigel RJ
    Oncogene; 2006 Apr; 25(15):2148-59. PubMed ID: 16288208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
    Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
    BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse double minute 2 associates with chromatin in the presence of p53 and is released to facilitate activation of transcription.
    White DE; Talbott KE; Arva NC; Bargonetti J
    Cancer Res; 2006 Apr; 66(7):3463-70. PubMed ID: 16585169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Oct-1 in the regulation of CDKN1A in response to clinically relevant doses of ionizing radiation.
    Nenoi M; Daino K; Nakajima T; Wang B; Taki K; Kakimoto A
    Biochim Biophys Acta; 2009 Mar; 1789(3):225-31. PubMed ID: 19118657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter.
    St Clair S; Giono L; Varmeh-Ziaie S; Resnick-Silverman L; Liu WJ; Padi A; Dastidar J; DaCosta A; Mattia M; Manfredi JJ
    Mol Cell; 2004 Dec; 16(5):725-36. PubMed ID: 15574328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.